- Home
- BRNS vs SHLT Comparison
BRNS vs SHLT Comparison
Compare BRNS & SHLT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- BRNS
- SHLT
- Stock Information
- Founded
- BRNS 2016
- SHLT 1987
- Country
- BRNS United Kingdom
- SHLT Israel
- Employees
- BRNS N/A
- SHLT N/A
- Industry
- BRNS Biotechnology: Pharmaceutical Preparations
- SHLT Business Services
- Sector
- BRNS Health Care
- SHLT Consumer Discretionary
- Exchange
- BRNS Nasdaq
- SHLT Nasdaq
- Market Cap
- BRNS 52.0M
- SHLT 49.7M
- IPO Year
- BRNS 2021
- SHLT N/A
- Fundamental
- Price
- BRNS $0.97
- SHLT $2.85
- Analyst Decision
- BRNS Strong Buy
- SHLT Strong Buy
- Analyst Count
- BRNS 2
- SHLT 1
- Target Price
- BRNS $4.00
- SHLT $11.00
- AVG Volume (30 Days)
- BRNS 31.7K
- SHLT 3.6K
- Earning Date
- BRNS 11-06-2024
- SHLT 09-26-2024
- Dividend Yield
- BRNS N/A
- SHLT N/A
- EPS Growth
- BRNS N/A
- SHLT N/A
- EPS
- BRNS N/A
- SHLT N/A
- Revenue
- BRNS $14,969,000.00
- SHLT $55,939,000.00
- Revenue This Year
- BRNS N/A
- SHLT N/A
- Revenue Next Year
- BRNS N/A
- SHLT N/A
- P/E Ratio
- BRNS N/A
- SHLT N/A
- Revenue Growth
- BRNS 106.21
- SHLT N/A
- 52 Week Low
- BRNS $0.88
- SHLT $2.54
- 52 Week High
- BRNS $4.16
- SHLT $9.48
- Technical
- Relative Strength Index (RSI)
- BRNS 30.37
- SHLT 48.19
- Support Level
- BRNS $1.28
- SHLT $2.67
- Resistance Level
- BRNS $1.52
- SHLT $3.00
- Average True Range (ATR)
- BRNS 0.13
- SHLT 0.13
- MACD
- BRNS -0.04
- SHLT 0.03
- Stochastic Oscillator
- BRNS 14.09
- SHLT 62.00
About BRNS Barinthus Biotherapeutics plc
Barinthus Biotherapeutics PLC is a clinical-stage biopharmaceutical company developing novel T cell immunotherapeutic that guide the immune system to overcome chronic infectious diseases, autoimmunity and cancer.
About SHLT SHL Telemedicine Ltd
SHL Telemedicine Ltd develops and markets personal telemedicine solutions. It consists of the transmission of medical data by an individual, from a remote location to a medical call center through telecommunication networks. The company offers solutions to subscribing patients, health insurance companies, hospitals, clinics, and physicians. It provides healthcare professional solutions to patients suffering from congestive heart failure, chronic obstructive pulmonary disease, and readmission solutions for reducing heart-related readmissions. In addition, consumer solutions include cardiac monitoring services. The company's geographical segments Israel, Europe, and the rest of the world, out of which majority revenue comes from Israel.